While preclinical models of ICI myocarditis consistently show the vital involvement of CD8+ T cells and fulminant inflammation in the myocardial tissue, several models with ICI treatment report a milder response, with smoldering inflammatory changes and a consistent decline in cardiac function. The gene discussed is CD8A; the disease is myocarditis.